Cost-Effectiveness Analysis of Antiviral Therapies for Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients in China

被引：0
作者：
Chi Zhang
Weixia Ke
Yanhui Gao
Shudong Zhou
Li Liu
Xiaohua Ye
Zhenjiang Yao
Yi Yang
机构：
[1] Guangdong Pharmaceutical University,Department of Epidemiology and Biostatistics and Guangdong Key Lab of Molecular Epidemiology, School of Public Health
来源：
Clinical Drug Investigation | 2015年 / 35卷
关键词：
Lamivudine; Adefovir; Entecavir; Probabilistic Sensitivity Analysis; HBeAg Seroconversion;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：197 / 209
页数：12
相关论文
共 223 条
  • [41] Lok AS(2005)Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra Health Econ. 14 339-347
  • [42] McMahon BJ(2004)The cost of managing chronic hepatitis B infection: a global perspective J Clin Gastroenterol. 38 S132-S133
  • [43] Liaw YF(2009)Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B J Hepatol. 51 640-646
  • [44] Kao JH(2008)A cost-effectiveness analysis of currently approved treatments for HBeAg-positive chronic hepatitis B Pharmacoeconomics. 26 937-949
  • [45] Priatvisuth T(2012)Cost-effectiveness of nucleoside/nucleotide analogues in chronic hepatitis B Rev Saude Publica. 46 942-949
  • [46] Chan LY(2006)Predicting cirrhosis risk based on the level of circulating hepatitis B viral load Gastroenterology. 130 678-686
  • [47] Chien RN(undefined)undefined undefined undefined undefined-undefined
  • [48] Liu CJ(undefined)undefined undefined undefined undefined-undefined
  • [49] Wu B(undefined)undefined undefined undefined undefined-undefined
  • [50] Li T(undefined)undefined undefined undefined undefined-undefined
12345678910